Cifurtilimab Antibody
Cifurtilimab (SEA-CD40) is a humanized agonistic anti-CD40 monoclonal antibody engineered for enhanced FcγRIIIa binding. It demonstrates anticancer activity in preclinical models of pancreatic cancer, lymphoma, and other solid tumors, supporting its investigation in both in vitro immune activation assays and in vivo oncology research.
Product Specifications
Product Name Alternative
Cifurtilimab
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
6 mg/mL
Purity
95.10% (May vary between batches)
Molecular Weight
145.10 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog